Reuters logo
BRIEF-Theravance Biopharma reports positive clinical response rates for patients in TOUR observational patient registry
2017年4月24日 / 下午12点50分 / 6 个月前

BRIEF-Theravance Biopharma reports positive clinical response rates for patients in TOUR observational patient registry

April 24 (Reuters) - Theravance Biopharma Inc:

* Theravance Biopharma reports positive clinical response rates for patients in TOUR™ observational patient registry in several presentations at ECCMID 2017

* Theravance Biopharma inc says vibativ was generally well tolerated in these patients with adverse event type

* Theravance Biopharma says there were six deaths within 28 days of first vibativ dose and two patients discontinued treatment due to an adverse event

* Theravance Biopharma -of 36 patients, 8 patients had at least 1 adverse event & 4 patients had at least one serious adverse event treated with vibativ Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below